MedTrace Logo

Evaluation of a New Medical Device AL539 in Patients With Obstructive Apneas Sleep Syndrome

NCT01441622 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2014-06-30

No results posted yet for this study

Summary

Continuous Positive Airway Pressure (CPAP) is the standard treatment in patients with Obstructive Sleep Apnea Syndrome (OSAS).

The goal of the study is to evaluate CPAP treatment duration recorded by the AL539 during attended in-hospital polysomnography in patients with Obstructive Sleep Apnea Syndrome.

Conditions

  • Obstructive Sleep Apnea Syndrome

Interventions

DEVICE

AL539 (SRETT)

recording data with AL539 (SRETT)

Sponsors & Collaborators

  • Atlanstat

    collaborator INDUSTRY

  • Air Liquide Santé International

    lead INDUSTRY

Principal Investigators

  • Damien LEGER, Pr · Hôpital Hôtel Dieu

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01441622 on ClinicalTrials.gov